These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice. Weiss S; Tzavara ET; Davis RJ; Nomikos GG; Michael McIntosh J; Giros B; Martres MP Neuropharmacology; 2007 Jun; 52(7):1496-508. PubMed ID: 17433376 [TBL] [Abstract][Full Text] [Related]
26. Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background. Morice E; Denis C; Giros B; Nosten-Bertrand M Eur J Neurosci; 2004 Jul; 20(1):120-6. PubMed ID: 15245485 [TBL] [Abstract][Full Text] [Related]
27. A new "sudden fright paradigm" to explore the role of (epi)genetic modulations of the DAT gene in fear-induced avoidance behavior. Zelli S; Brancato A; Mattioli F; Pepe M; Alleva E; Carbone C; Cannizzaro C; Adriani W Genes Brain Behav; 2021 Apr; 20(4):e12709. PubMed ID: 33070435 [TBL] [Abstract][Full Text] [Related]
28. Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine. Uchiumi O; Kasahara Y; Fukui A; Hall FS; Uhl GR; Sora I Neuropharmacology; 2013 Jan; 64():348-56. PubMed ID: 22809709 [TBL] [Abstract][Full Text] [Related]
30. Deficit in working memory and abnormal behavioral tactics in dopamine transporter knockout rats during training in the 8-arm maze. Kurzina NP; Aristova IY; Volnova AB; Gainetdinov RR Behav Brain Res; 2020 Jul; 390():112642. PubMed ID: 32428629 [TBL] [Abstract][Full Text] [Related]
31. Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice. Chen R; Furman CA; Zhang M; Kim MN; Gereau RW; Leitges M; Gnegy ME J Pharmacol Exp Ther; 2009 Mar; 328(3):912-20. PubMed ID: 19098163 [TBL] [Abstract][Full Text] [Related]
32. Motor Transitions' Peculiarity of Heterozygous DAT Rats When Offspring of an Unconventional KOxWT Mating. Carbone C; Brancato A; Adinolfi A; Lo Russo SLM; Alleva E; Cannizzaro C; Adriani W Neuroscience; 2020 May; 433():108-120. PubMed ID: 32171819 [TBL] [Abstract][Full Text] [Related]
33. Toward evidence-based severity assessment in rat models with repeated seizures: III. Electrical post-status epilepticus model. Seiffert I; van Dijk RM; Koska I; Di Liberto V; Möller C; Palme R; Hellweg R; Potschka H Epilepsia; 2019 Aug; 60(8):1539-1551. PubMed ID: 31247135 [TBL] [Abstract][Full Text] [Related]
34. Reward sensitivity deficits in a rat model of compulsive eating behavior. Moore CF; Leonard MZ; Micovic NM; Miczek KA; Sabino V; Cottone P Neuropsychopharmacology; 2020 Mar; 45(4):589-596. PubMed ID: 31622973 [TBL] [Abstract][Full Text] [Related]
35. Dopaminergic modulation of the circadian activity and sociability: Dissecting parental inheritance versus maternal styles as determinants of epigenetic influence. Oggiano M; Buccheri C; Alleva E; Adriani W Behav Brain Res; 2022 Jan; 417():113623. PubMed ID: 34624423 [TBL] [Abstract][Full Text] [Related]
36. Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Ralph-Williams RJ; Paulus MP; Zhuang X; Hen R; Geyer MA Biol Psychiatry; 2003 Feb; 53(4):352-9. PubMed ID: 12586455 [TBL] [Abstract][Full Text] [Related]
37. Multiscale imaging characterization of dopamine transporter knockout mice reveals regional alterations in spine density of medium spiny neurons. Berlanga ML; Price DL; Phung BS; Giuly R; Terada M; Yamada N; Cyr M; Caron MG; Laakso A; Martone ME; Ellisman MH Brain Res; 2011 May; 1390():41-9. PubMed ID: 21439946 [TBL] [Abstract][Full Text] [Related]
38. The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. Barr AM; Lehmann-Masten V; Paulus M; Gainetdinov RR; Caron MG; Geyer MA Neuropsychopharmacology; 2004 Feb; 29(2):221-8. PubMed ID: 14603268 [TBL] [Abstract][Full Text] [Related]
39. Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease. Miller GW; Wang YM; Gainetdinov RR; Caron MG Methods Mol Med; 2001; 62():179-90. PubMed ID: 21318776 [TBL] [Abstract][Full Text] [Related]
40. Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems. Hall FS; Itokawa K; Schmitt A; Moessner R; Sora I; Lesch KP; Uhl GR Neuropharmacology; 2014 Jan; 76 Pt A(0 0):146-55. PubMed ID: 23978383 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]